South Africa Hailed for 'Revolutionary' Step in Treating TB

Doctors Without Borders has welcomed the South African National Department of Health's announcement that it would use bedaquiline, a promising new oral medicine, instead of injectable medication with harmful side effects. Adolescents and adults suffering from multidrug-resistant  tuberculosis will be administered the treatment as part of their standard regimen.

A South African XDR-TB patient receiving his Bedaquiline and delamanid.

Simbongile’s current DR-TB regimen: bedaquiline, linezolid, clofazimine, terizidone, levofloxacin, pyrazinamide.


See What Everyone is Watching

Don't Miss

AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.